Enhanced Electrocatalytic Activity of Amorphized LaCoO3 for Oxygen Evolution Reaction
Increasing energy demands and fossil fuel depletion urges scientists to develop renewable catalysts for energy production. Amorphous catalysts are the emerging electrocatalysts due to their structural flexibility. Herein, crystalline LaCoO3 is transformed to amorphous by urea reduction treatment. The catalyst synthesized at 450 °C (LCO-4) exhibits excellent OER activity.
Abstract
Amorphous inorganic perovskites have attracted significant attention as efficient electrocatalysts due to their unique structural flexibility and good catalytic activity. In particular, the disordered structure and a surface rich in defects such as oxygen vacancies can contribute to the superior electrocatalytic activity of amorphous oxides compared to their crystalline counterpart. In this work, we report the synthesis of LaCoO3, followed by an amorphization process through urea reduction with tailored modifications. The as-synthesized catalysts were thoroughly tested for their performance in oxygen evolution reaction (OER), Remarkably, the amorphous LaCoO3 synthesized at 450 °C (referred to as LCO-4) exhibits excellent OER catalytic activity. At an overpotential of 310 mV, it achieved a current density of 10 mA/cm−2, exceedingly fast to 1 A/cm−2 at an overpotential of only 460 mV. Moreover, LCO-4 exhibited several advantageous features compared to pristine LaCoO3 and LaCoO3 amorphized at other two temperatures (350 °C, LCO-3, and 550 °C, LCO-5). The amorphized LCO-4 catalyst showed a higher electrochemically active surface area, a key factor in boosting catalytic performance. Additionally, LCO-4 demonstrated the lowest Tafel slope of 70 mVdec−1, further highlighting its exceptional OER activity. Furthermore, the long-term stability of LCO-4 is notably superior than pristine LaCoO3 (LCO-P) and the other amorphized samples (LCO-3 and LCO-5). The enhanced catalytic activity of LCO-4 can be attributed to its unique disordered structure, small crystallite size, and higher concentration of oxygen vacancies in the final catalyst.
A Tight Contact: The Expanding Application of Salicylaldehydes in Lysine‐Targeting Covalent Drugs
Salicylaldehyde-bearing ligands can bind the protein targets forming imines with lysine-amino groups. This drug design improves the affinity and selectivity for specific biological targets. Given the abundance of lysine residues in proteins and the reversible covalent (RC) nature of ligand-protein interaction, SA-bearing ligands hold significant promise for future pharmaceutical applications.
Abstract
The installation of aldehydes into synthetic protein ligands is an efficient strategy to engage protein lysine residues in remarkably stable imine bonds and augment the compound affinity and selectivity for their biological targets. The high frequency of lysine residues in proteins and the reversibility of the covalent ligand-protein bond support the application of aldehyde-bearing ligands, holding promises for their future use as drugs. This review highlights the increasing exploitation of salicylaldehyde modules in various classes of protein binders, aimed at the reversible-covalent engagement of lysine residues.